The Asia-Pacific IgG4-Related Disease Market was valued at USD 387.49 Million in 2020 and is expected to reach USD 522.91 Million by 2028, growing at a CAGR of 4.2% (2021-2028).

The North America IgG4-Related Disease Market was valued at USD 1,856.39 Million in 2020 and is expected to reach USD 2,490.06 Million by 2028, growing at a CAGR of 4.1% (2021-2028).

The Europe IgG4-Related Disease Market was valued at USD 713.58 Million in 2020 and is expected to reach USD 925.98 Million by 2028, growing at a CAGR of 3.7% (2021-2028).

The Middle East and Africa IgG4-Related Disease Market was valued at USD 83.72 Million in 2020 and is expected to reach USD 97.82 Million by 2028, growing at a CAGR of 2.3% (2021-2028).